Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

MLA

E. Genescà, et al. “Frequency and Clinical Impact of CDKN2A/ARF/CDKN2B Gene Deletions as Assessed by in-Depth Genetic Analyses in Adult T Cell Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology, vol. 11, no. 1, July 2018, pp. 1–4. EBSCOhost, https://doi.org/10.1186/s13045-018-0639-8.

APA

E. Genescà, A. Lazarenkov, M. Morgades, G. Berbis, N. Ruíz-Xivillé, P. Gómez-Marzo, J. Ribera, J. Juncà, A. González-Pérez, S. Mercadal, R. Guardia, M. T. Artola, M. J. Moreno, J. Martínez-López, L. Zamora, P. Barba, C. Gil, M. Tormo, A. Cladera, … J. M. Ribera. (2018). Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia. Journal of Hematology & Oncology, 11(1), 1–4. https://doi.org/10.1186/s13045-018-0639-8

Chicago

E. Genescà, A. Lazarenkov, M. Morgades, G. Berbis, N. Ruíz-Xivillé, P. Gómez-Marzo, J. Ribera, et al. 2018. “Frequency and Clinical Impact of CDKN2A/ARF/CDKN2B Gene Deletions as Assessed by in-Depth Genetic Analyses in Adult T Cell Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology 11 (1): 1–4. doi:10.1186/s13045-018-0639-8.